Elevated serum interleukin-18 levels might reflect the high risk of hospitalization in patients on peritoneal dialysis

A. I. Yano, Kazushi Nakao, A. I. Sarai, Shigeru Akagi, Takashi Kihara, Hisanori Morimoto, Akihiko Nakamura, Makoto Hiramatsu, Yoshio Nagake, Hirofumi Makino

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: Interleukin (IL)-18 is a potent pro-inflammatory cytokine and plays a central role in atherosclerotic plaque rupture and accelerates atherosclerosis. Aim: The aim of this study was to determine serum IL-18 levels in patients on peritoneal dialysis (PD) and to assess their relationship with hospitalization. Methods: Forty-three PD patients and 20 healthy individuals were enrolled in this study. We investigated the relationship of the serum concentrations of IL-18 and other well-established atherosclerotic markers, such as asymmetric dimethylarginine (ADMA). Hospitalization data from over a 18-month period were prospectively obtained on all 43 PD patients. Classic factors were entered into a Cox regression model to predict first hospitalization. Results: The serum levels of IL-18 in patients on PD were significantly higher than those of healthy individuals (228.5 ± 140.3 pg/mL vs 154.8 ± 44.7 pg/mL, P < 0.05, respectively). Furthermore, serum IL-18 levels showed a positive correlation with duration of PD, serum β2 microglobulin and serum ADMA levels. Mean serum levels of IL-18 were significantly higher among patients who had experienced at least one hospitalization than those who had not (279.9 ± 164.3 vs 158.5 ± 43.9 pg/mL, P = 0.0426). Furthermore, the relative risk for first hospitalization for each increase in IL-18 (pg/mL) levels was associated with a 1.182 (95% confidence interval, 1.012-1.364; P = 0.0071) increase in the risk for future hospitalization events. Conclusion: The present study suggests the elevated serum IL-18 levels might increase the risk for future hospitalization in patients on PD.

Original languageEnglish
Pages (from-to)576-582
Number of pages7
JournalNephrology
Volume10
Issue number6
DOIs
Publication statusPublished - Dec 1 2005

Fingerprint

Interleukin-18
Peritoneal Dialysis
Hospitalization
Serum
Atherosclerotic Plaques
Proportional Hazards Models
Rupture
Atherosclerosis
Confidence Intervals
Cytokines

Keywords

  • Asymmetric dimethylarginine
  • Hospitalization
  • Interleukin-18
  • Peritoneal dialysis

ASJC Scopus subject areas

  • Nephrology

Cite this

Elevated serum interleukin-18 levels might reflect the high risk of hospitalization in patients on peritoneal dialysis. / Yano, A. I.; Nakao, Kazushi; Sarai, A. I.; Akagi, Shigeru; Kihara, Takashi; Morimoto, Hisanori; Nakamura, Akihiko; Hiramatsu, Makoto; Nagake, Yoshio; Makino, Hirofumi.

In: Nephrology, Vol. 10, No. 6, 01.12.2005, p. 576-582.

Research output: Contribution to journalArticle

Yano, AI, Nakao, K, Sarai, AI, Akagi, S, Kihara, T, Morimoto, H, Nakamura, A, Hiramatsu, M, Nagake, Y & Makino, H 2005, 'Elevated serum interleukin-18 levels might reflect the high risk of hospitalization in patients on peritoneal dialysis', Nephrology, vol. 10, no. 6, pp. 576-582. https://doi.org/10.1111/j.1440-1797.2005.00497.x
Yano, A. I. ; Nakao, Kazushi ; Sarai, A. I. ; Akagi, Shigeru ; Kihara, Takashi ; Morimoto, Hisanori ; Nakamura, Akihiko ; Hiramatsu, Makoto ; Nagake, Yoshio ; Makino, Hirofumi. / Elevated serum interleukin-18 levels might reflect the high risk of hospitalization in patients on peritoneal dialysis. In: Nephrology. 2005 ; Vol. 10, No. 6. pp. 576-582.
@article{526befc53b314edc8ce98f21a01a8910,
title = "Elevated serum interleukin-18 levels might reflect the high risk of hospitalization in patients on peritoneal dialysis",
abstract = "Background: Interleukin (IL)-18 is a potent pro-inflammatory cytokine and plays a central role in atherosclerotic plaque rupture and accelerates atherosclerosis. Aim: The aim of this study was to determine serum IL-18 levels in patients on peritoneal dialysis (PD) and to assess their relationship with hospitalization. Methods: Forty-three PD patients and 20 healthy individuals were enrolled in this study. We investigated the relationship of the serum concentrations of IL-18 and other well-established atherosclerotic markers, such as asymmetric dimethylarginine (ADMA). Hospitalization data from over a 18-month period were prospectively obtained on all 43 PD patients. Classic factors were entered into a Cox regression model to predict first hospitalization. Results: The serum levels of IL-18 in patients on PD were significantly higher than those of healthy individuals (228.5 ± 140.3 pg/mL vs 154.8 ± 44.7 pg/mL, P < 0.05, respectively). Furthermore, serum IL-18 levels showed a positive correlation with duration of PD, serum β2 microglobulin and serum ADMA levels. Mean serum levels of IL-18 were significantly higher among patients who had experienced at least one hospitalization than those who had not (279.9 ± 164.3 vs 158.5 ± 43.9 pg/mL, P = 0.0426). Furthermore, the relative risk for first hospitalization for each increase in IL-18 (pg/mL) levels was associated with a 1.182 (95{\%} confidence interval, 1.012-1.364; P = 0.0071) increase in the risk for future hospitalization events. Conclusion: The present study suggests the elevated serum IL-18 levels might increase the risk for future hospitalization in patients on PD.",
keywords = "Asymmetric dimethylarginine, Hospitalization, Interleukin-18, Peritoneal dialysis",
author = "Yano, {A. I.} and Kazushi Nakao and Sarai, {A. I.} and Shigeru Akagi and Takashi Kihara and Hisanori Morimoto and Akihiko Nakamura and Makoto Hiramatsu and Yoshio Nagake and Hirofumi Makino",
year = "2005",
month = "12",
day = "1",
doi = "10.1111/j.1440-1797.2005.00497.x",
language = "English",
volume = "10",
pages = "576--582",
journal = "Nephrology",
issn = "1320-5358",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Elevated serum interleukin-18 levels might reflect the high risk of hospitalization in patients on peritoneal dialysis

AU - Yano, A. I.

AU - Nakao, Kazushi

AU - Sarai, A. I.

AU - Akagi, Shigeru

AU - Kihara, Takashi

AU - Morimoto, Hisanori

AU - Nakamura, Akihiko

AU - Hiramatsu, Makoto

AU - Nagake, Yoshio

AU - Makino, Hirofumi

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Background: Interleukin (IL)-18 is a potent pro-inflammatory cytokine and plays a central role in atherosclerotic plaque rupture and accelerates atherosclerosis. Aim: The aim of this study was to determine serum IL-18 levels in patients on peritoneal dialysis (PD) and to assess their relationship with hospitalization. Methods: Forty-three PD patients and 20 healthy individuals were enrolled in this study. We investigated the relationship of the serum concentrations of IL-18 and other well-established atherosclerotic markers, such as asymmetric dimethylarginine (ADMA). Hospitalization data from over a 18-month period were prospectively obtained on all 43 PD patients. Classic factors were entered into a Cox regression model to predict first hospitalization. Results: The serum levels of IL-18 in patients on PD were significantly higher than those of healthy individuals (228.5 ± 140.3 pg/mL vs 154.8 ± 44.7 pg/mL, P < 0.05, respectively). Furthermore, serum IL-18 levels showed a positive correlation with duration of PD, serum β2 microglobulin and serum ADMA levels. Mean serum levels of IL-18 were significantly higher among patients who had experienced at least one hospitalization than those who had not (279.9 ± 164.3 vs 158.5 ± 43.9 pg/mL, P = 0.0426). Furthermore, the relative risk for first hospitalization for each increase in IL-18 (pg/mL) levels was associated with a 1.182 (95% confidence interval, 1.012-1.364; P = 0.0071) increase in the risk for future hospitalization events. Conclusion: The present study suggests the elevated serum IL-18 levels might increase the risk for future hospitalization in patients on PD.

AB - Background: Interleukin (IL)-18 is a potent pro-inflammatory cytokine and plays a central role in atherosclerotic plaque rupture and accelerates atherosclerosis. Aim: The aim of this study was to determine serum IL-18 levels in patients on peritoneal dialysis (PD) and to assess their relationship with hospitalization. Methods: Forty-three PD patients and 20 healthy individuals were enrolled in this study. We investigated the relationship of the serum concentrations of IL-18 and other well-established atherosclerotic markers, such as asymmetric dimethylarginine (ADMA). Hospitalization data from over a 18-month period were prospectively obtained on all 43 PD patients. Classic factors were entered into a Cox regression model to predict first hospitalization. Results: The serum levels of IL-18 in patients on PD were significantly higher than those of healthy individuals (228.5 ± 140.3 pg/mL vs 154.8 ± 44.7 pg/mL, P < 0.05, respectively). Furthermore, serum IL-18 levels showed a positive correlation with duration of PD, serum β2 microglobulin and serum ADMA levels. Mean serum levels of IL-18 were significantly higher among patients who had experienced at least one hospitalization than those who had not (279.9 ± 164.3 vs 158.5 ± 43.9 pg/mL, P = 0.0426). Furthermore, the relative risk for first hospitalization for each increase in IL-18 (pg/mL) levels was associated with a 1.182 (95% confidence interval, 1.012-1.364; P = 0.0071) increase in the risk for future hospitalization events. Conclusion: The present study suggests the elevated serum IL-18 levels might increase the risk for future hospitalization in patients on PD.

KW - Asymmetric dimethylarginine

KW - Hospitalization

KW - Interleukin-18

KW - Peritoneal dialysis

UR - http://www.scopus.com/inward/record.url?scp=29144459564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29144459564&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1797.2005.00497.x

DO - 10.1111/j.1440-1797.2005.00497.x

M3 - Article

C2 - 16354240

AN - SCOPUS:29144459564

VL - 10

SP - 576

EP - 582

JO - Nephrology

JF - Nephrology

SN - 1320-5358

IS - 6

ER -